JP2008530176A5 - - Google Patents

Download PDF

Info

Publication number
JP2008530176A5
JP2008530176A5 JP2007555588A JP2007555588A JP2008530176A5 JP 2008530176 A5 JP2008530176 A5 JP 2008530176A5 JP 2007555588 A JP2007555588 A JP 2007555588A JP 2007555588 A JP2007555588 A JP 2007555588A JP 2008530176 A5 JP2008530176 A5 JP 2008530176A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally
coo
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007555588A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008530176A (ja
JP5140434B2 (ja
Filing date
Publication date
Priority claimed from DE102005007654A external-priority patent/DE102005007654A1/de
Application filed filed Critical
Publication of JP2008530176A publication Critical patent/JP2008530176A/ja
Publication of JP2008530176A5 publication Critical patent/JP2008530176A5/ja
Application granted granted Critical
Publication of JP5140434B2 publication Critical patent/JP5140434B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007555588A 2005-02-19 2006-02-13 呼吸系疾患を治療するための新規な長く作用するベータミメチックス Expired - Fee Related JP5140434B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005007654A DE102005007654A1 (de) 2005-02-19 2005-02-19 Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen
DE102005007654.8 2005-02-19
PCT/EP2006/050898 WO2006087315A1 (de) 2005-02-19 2006-02-13 Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen

Publications (3)

Publication Number Publication Date
JP2008530176A JP2008530176A (ja) 2008-08-07
JP2008530176A5 true JP2008530176A5 (enExample) 2009-04-02
JP5140434B2 JP5140434B2 (ja) 2013-02-06

Family

ID=36607505

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007555588A Expired - Fee Related JP5140434B2 (ja) 2005-02-19 2006-02-13 呼吸系疾患を治療するための新規な長く作用するベータミメチックス

Country Status (10)

Country Link
US (1) US7423036B2 (enExample)
EP (1) EP1853596B1 (enExample)
JP (1) JP5140434B2 (enExample)
AR (1) AR053135A1 (enExample)
AT (1) ATE496913T1 (enExample)
CA (1) CA2598355A1 (enExample)
DE (2) DE102005007654A1 (enExample)
ES (1) ES2357620T3 (enExample)
TW (1) TW200640911A (enExample)
WO (1) WO2006087315A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
EP2057152A1 (de) * 2006-08-07 2009-05-13 Boehringer Ingelheim International GmbH Enantiomerenreine betaagonisten, verfahren zu deren herstellung und deren verwendung als arzneimittel
CA2660186A1 (en) * 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
GB0913342D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab Compounds - 801
WO2011048409A1 (en) 2009-10-20 2011-04-28 Astrazeneca Ab Cyclic amine derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
GB201009801D0 (en) 2010-06-11 2010-07-21 Astrazeneca Ab Compounds 950
JO3192B1 (ar) 2011-09-06 2018-03-08 Novartis Ag مركب بنزوثيازولون

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4460581A (en) 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
SK15382002A3 (sk) 2000-04-27 2003-03-04 Boehringer Ingelheim Pharma Kg Betamimetiká, farmaceutický prostriedok s ich obsahom a ich použitie
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
PE20050130A1 (es) * 2002-08-09 2005-03-29 Novartis Ag Compuestos organicos
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
BRPI0409198A (pt) * 2003-04-04 2006-05-02 Novartis Ag derivados quinolin-2-ona para o tratamento de doenças de vias aéreas
EP1651221B1 (en) * 2003-07-28 2009-01-14 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising betamimetics and an anticholinergic agent
EP1654001A2 (en) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and a betamimetic
US7405232B2 (en) 2004-02-14 2008-07-29 Boehringer Ingelheim International Gmbh Long acting beta-2 agonists and their use as medicaments
DE502005010170D1 (de) * 2004-02-14 2010-10-14 Boehringer Ingelheim Pharma Neue langwirksame beta-2-agonisten, und deren verwendung als arzneimittel
DE102004024453A1 (de) * 2004-05-14 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7745621B2 (en) 2004-05-14 2010-06-29 Boehringer Ingelheim International Gmbh Long acting bronchodilators for the treatment of respiratory diseases

Similar Documents

Publication Publication Date Title
JP2008530176A5 (enExample)
JP2017528503A5 (enExample)
JP2005516067A5 (enExample)
JP2005525323A5 (enExample)
JP2005525322A5 (enExample)
JP2006524206A5 (enExample)
JP2004511556A5 (enExample)
JP2014037426A5 (enExample)
JP2007502804A5 (enExample)
JP2018514568A5 (enExample)
JP2004517099A5 (enExample)
JP2017528507A5 (enExample)
JP2017512191A5 (enExample)
JP2005509622A5 (enExample)
JP2009534405A5 (enExample)
CN1251524A (zh) 用于口服给药n-哌啶子基-3-吡唑甲酰胺衍生物、其盐及其溶剂化物的药物组合物
JP2009524676A5 (enExample)
JP2014514349A5 (enExample)
JP2008540672A (ja) 病状に起因する性的機能不全の治療方法
EP2397476A3 (en) Indole derivative having PGD2 receptor antagonist activity
JP2006523193A5 (enExample)
JP2005505618A5 (enExample)
JP2018500287A5 (enExample)
JP2010155827A5 (enExample)
JP2015508068A5 (enExample)